Zurcher Kantonalbank (Zurich Cantonalbank) - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$32,362
-47.4%
39,4660.0%0.00%
Q4 2022$61,567
+31.0%
39,466
+44.0%
0.00%
Q3 2022$47,0000.0%27,3990.0%0.00%
Q2 2022$47,000
-52.0%
27,3990.0%0.00%
Q1 2022$98,000
-28.5%
27,3990.0%0.00%
-100.0%
Q4 2021$137,000
-2.1%
27,399
+40.5%
0.00%0.0%
Q3 2021$140,000
-22.7%
19,4960.0%0.00%0.0%
Q2 2021$181,000
-15.4%
19,496
-15.3%
0.00%0.0%
Q1 2021$214,000
+4.9%
23,0120.0%0.00%0.0%
Q4 2020$204,000
+10.3%
23,012
+44.6%
0.00%0.0%
Q3 2020$185,000
-56.9%
15,9140.0%0.00%
-75.0%
Q2 2020$429,000
+3475.0%
15,914
+178.1%
0.00%
Q3 2019$12,000
-29.4%
5,7230.0%0.00%
Q2 2019$17,000
-19.0%
5,7230.0%0.00%
Q1 2019$21,000
-8.7%
5,7230.0%0.00%
Q4 2018$23,000
+76.9%
5,723
+142.6%
0.00%
Q3 2018$13,000
+44.4%
2,3590.0%0.00%
Q2 2018$9,000
-18.2%
2,3590.0%0.00%
Q1 2018$11,000
+10.0%
2,3590.0%0.00%
Q4 2017$10,000
-33.3%
2,3590.0%0.00%
Q3 2017$15,000
-16.7%
2,3590.0%0.00%
Q2 2017$18,000
+12.5%
2,3590.0%0.00%
Q1 2017$16,0000.0%2,3590.0%0.00%
Q4 2016$16,000
-27.3%
2,3590.0%0.00%
Q3 2016$22,000
+37.5%
2,359
+37.2%
0.00%
Q2 2016$16,000
+6.7%
1,7200.0%0.00%
Q1 2016$15,000
+25.0%
1,7200.0%0.00%
Q4 2015$12,000
+20.0%
1,7200.0%0.00%
Q3 2015$10,0001,7200.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders